Long-Term Nonprogressive Interstitial Lung Disease in Anti-PL-12- and Anti-Ro52-Positive Antisynthetase Syndrome Without Immunosuppressive Therapy. [PDF]
Almaalouli B, Choula HR, Rodriguez M.
europepmc +1 more source
Successful Treatment of Diffuse Large B-Cell Lymphoma and Antisynthetase Syndrome with Bispecific Antibody Glofitamab. [PDF]
Wei C +4 more
europepmc +1 more source
Epidemiology of Antisynthetase Syndrome and Risk of Malignancy in a Population-Based Cohort (1998-2019). [PDF]
Coffey CM +4 more
europepmc +1 more source
Clinical features and therapeutic challenges of psoriatic arthritis coexisting with antisynthetase syndrome: a case report and literature review. [PDF]
Yan R +6 more
europepmc +1 more source
Monocyte-driven IFN and TNF programs orchestrate inflammatory networks in antisynthetase syndrome-associated interstitial lung disease. [PDF]
Fan Y +8 more
europepmc +1 more source
Comments to the "Letter to the Editor" for the manuscript titled "Clinico-sero-pathological characteristics of anti-Ha antisynthetase syndrome". [PDF]
Zhao B, Zhang L, Dai T.
europepmc +1 more source
Anti-PL-12 and Interstitial Lung Disease as the First Signs of Antisynthetase Syndrome in Patients With Previously Diagnosed Systemic Lupus Erythematosus. [PDF]
Djuran I +4 more
europepmc +1 more source
AI-powered CT imaging for early detection of subclinical pulmonary fibrosis in antisynthetase syndrome: a new era in autoimmune lung diagnostics. [PDF]
Zubair A +4 more
europepmc +1 more source
Clinico-sero-pathological characteristics of anti-Ha antisynthetase syndrome. [PDF]
Zhao B +9 more
europepmc +1 more source
Correction: Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report. [PDF]
Li Y +9 more
europepmc +1 more source

